A phase II trial of #volenrelaxin was terminated "due to a lack of foreseeable clinical benefit" in #CKD. #kidneydisease #nephrology #nephsky #drugdevelopment

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service